R1 RCM Inc. (NASDAQ:RCM) – Investment analysts at KeyCorp dropped their Q2 2021 earnings estimates for shares of R1 RCM in a research note issued to investors on Tuesday, January 12th. KeyCorp analyst D. Hooker now anticipates that the healthcare provider will post earnings per share of $0.06 for the quarter, down from their previous forecast of $0.07. KeyCorp currently has a “Overweight” rating and a $26.00 price target on the stock.
R1 RCM (NASDAQ:RCM) last released its quarterly earnings data on Tuesday, November 3rd. The healthcare provider reported $0.11 earnings per share (EPS) for the quarter. R1 RCM had a net margin of 4.02% and a return on equity of 182.08%. The firm had revenue of $307.20 million for the quarter, compared to the consensus estimate of $295.38 million. During the same period last year, the firm earned $0.01 earnings per share. The company’s quarterly revenue was up 2.0% on a year-over-year basis.
NASDAQ:RCM opened at $25.37 on Thursday. The stock has a market cap of $2.96 billion, a PE ratio of 253.73, a price-to-earnings-growth ratio of 20.19 and a beta of 0.57. R1 RCM has a fifty-two week low of $7.12 and a fifty-two week high of $25.60. The firm’s fifty day simple moving average is $22.61 and its 200-day simple moving average is $17.55. The company has a quick ratio of 1.27, a current ratio of 1.27 and a debt-to-equity ratio of 12.08.
A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Cubist Systematic Strategies LLC boosted its position in shares of R1 RCM by 87.3% during the third quarter. Cubist Systematic Strategies LLC now owns 116,720 shares of the healthcare provider’s stock worth $2,002,000 after buying an additional 54,387 shares during the period. Sei Investments Co. grew its holdings in R1 RCM by 138.5% during the 3rd quarter. Sei Investments Co. now owns 101,471 shares of the healthcare provider’s stock valued at $1,740,000 after purchasing an additional 58,927 shares in the last quarter. BlackRock Inc. lifted its position in R1 RCM by 109.4% in the 3rd quarter. BlackRock Inc. now owns 16,718,057 shares of the healthcare provider’s stock valued at $286,714,000 after purchasing an additional 8,734,205 shares during the last quarter. Great West Life Assurance Co. Can lifted its position in R1 RCM by 529.9% in the 3rd quarter. Great West Life Assurance Co. Can now owns 37,557 shares of the healthcare provider’s stock valued at $1,491,000 after purchasing an additional 31,595 shares during the last quarter. Finally, Allianz Asset Management GmbH lifted its position in R1 RCM by 24.3% in the 3rd quarter. Allianz Asset Management GmbH now owns 482,121 shares of the healthcare provider’s stock valued at $8,269,000 after purchasing an additional 94,208 shares during the last quarter.
About R1 RCM
R1 RCM Inc provides revenue cycle management (RCM) for healthcare providers in the United States. It offers end-to-end RCM services to manage their revenue cycle operations, which encompass patient registration, insurance and benefit verification, medical treatment documentation and coding, and bill preparation and collection from patients and payers.
Recommended Story: Green Investing
Receive News & Ratings for R1 RCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for R1 RCM and related companies with MarketBeat.com's FREE daily email newsletter.